Novan to Host Corporate Update Conference Call and Webcast on September 9, 2021

Rhea-AI Summary

Novan, Inc. (Nasdaq: NOVN) will host a corporate update conference call on September 9, 2021, at 8:30 a.m. ET, led by CEO Paula Brown Stafford and her management team. Participants can join via phone or the company's website, where the webcast will also be archived for 90 days. Novan focuses on developing nitric oxide-based therapies for various medical conditions, with its lead candidate, SB206, a topical antiviral gel aimed at treating molluscum, addressing a significant unmet need in dermatology.

– Conference call with live audio webcast to be held on Thursday, September 9^th at 8:30 a.m. ET –

DURHAM, N.C., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Novan management will host a corporate update conference call with live audio webcast on Thursday, September 9, 2021 at 8:30 a.m. ET.

The call will be led by Paula Brown Stafford, President and Chief Executive Officer of Novan, who will be joined by additional members of the Novan management team. Interested participants and investors may access the conference call by dialing (844) 707-0661 (domestic) or (703) 318-2240 (international) and referencing conference ID: 6243828. The live webcast will be accessible on the Events page of the Investors section of the Novan website, novan.com, and will be archived for 90 days.

About Novan

Novan, Inc. is a late clinical-stage biotechnology company focused on leveraging its proprietary nitric oxide (NO) based technology platform, NITRICIL™ to generate macromolecular New Chemical Entities (NCEs) to treat multiple indications in dermatology, men’s and women’s health, infectious diseases, and various other medical conditions with significant unmet needs. The Company’s lead product candidate is SB206, a topical gel with antiviral properties, for the treatment of molluscum. The Company believes that SB206 as a topical, at-home, caregiver-applied therapy with a rapid treatment benefit, if approved, would address an important unmet medical need for the treatment of molluscum.

INVESTOR AND MEDIA CONTACT:

Jenene Thomas
JTC Team, LLC
833-475-8247
NOVN@jtcir.com

FAQ

When is Novan's conference call scheduled for 2021?

Novan's conference call is scheduled for September 9, 2021, at 8:30 a.m. ET.

How can I access the Novan conference call?

You can access the Novan conference call by dialing (844) 707-0661 for domestic calls or (703) 318-2240 for international calls, using conference ID: 6243828.

What is Novan's lead product candidate?

Novan's lead product candidate is SB206, a topical gel with antiviral properties for the treatment of molluscum.

What technology does Novan utilize for its product development?

Novan utilizes its proprietary nitric oxide (NO) based technology platform, NITRICIL™, for developing therapeutic products.

Where can I find the archived Novan conference call?

The archived conference call can be found on the Events page of the Investors section of the Novan website for 90 days after the event.